series-a
Stage
1
Investors
About
Soley GmbH develops a software platform that automates chemical synthesis routes using AI and computational chemistry to accelerate drug discovery and chemical research.
Explore Soley GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.